FIELD: pharmacology.
SUBSTANCE: invention relates to new benzimidazole derivatives of the general formula I 
, where (Ia) R = n-propyl, (Ib) R = allyl, which has antiplatelet and antioxidant properties.
EFFECT: new benzimidazole derivatives are obtained, useful for myocardial infarction and stroke treatment.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 9-SUBSTITUTED-2-BIPHENYLIMIDAZO[1,2-A]BENZIMIDAZOLES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, HAVING ANTIOXIDANT AND ANTIRADICAL PROPERTIES | 2017 |
|
RU2649979C1 |
| 1-(3-MORPHOLINOPROPYL)-2-PHENYLIMIDAZO[1,2-a]-BENZIMIDAZOLE DIHYDROCHLORIDE, HAVING PURINE P2Y-RECEPTOR ANTAGONIST PROPERTIES, ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2008 |
|
RU2391345C2 |
| BROMIDES OF BENZIMIDAZOLIUM DERIVATIVES AS INHIBITORS OF PROTEIN-TYROSINEPHOSPHATASE 1B TYPE (PTP1B) | 2018 |
|
RU2652112C1 |
| MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM | 2013 |
|
RU2518741C1 |
| AGENT HAVING CARDIOPROTECTIVE ACTION AND 1,3-DISUBSTITUTED 2-AMINOBENZIMIDAZOLIUM HALIDES | 2013 |
|
RU2526902C1 |
| HYDROHALIDES OF 11-PHENOXYETHYL AND 11-BENZYL-SUBSTITUTED 2,3,4,5-TETRAHYDRO[1,3]DIAZEPINO[1,2-a] BENZIMIDAZOLE, HAVING ANTIAGGREGANT ACTIVITY | 2015 |
|
RU2582618C1 |
| 9-BENZYL-2-BIPHENYLIMIDAZO[1,2-A]BENZIMIDAZOLE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF THAT EXPRESS PROPERTIES OF DESTROYERS OF TRANSVERSAL CROSS-LINKS OF GLYCOSYLATED PROTEINS | 2016 |
|
RU2627769C1 |
| 2-AMINOPROPYLMORPHOLINO-5-ARYL-6H-1,3,4-THIADIAZINES, DIHYDROBROMIDES AND 2-AMINOPROPYLMORPHOLINO-4-ARYLTHIAZOLES, HYDROBROMIDES SHOWING ANTIAGGREGANT ACTION | 2011 |
|
RU2456284C1 |
| AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
| MEDICATIONS EXHIBITING PROPERTIES OF ANTAGONISTS OF SEROTONIN 5-HT- RECEPTORS | 2011 |
|
RU2465901C2 |
